CLSD - Clearside Biomedical, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5356
Avg. Estimate-0.1-0.14-0.85-0.48
Low Estimate-0.16-0.14-0.93-0.59
High Estimate0-0.14-0.71-0.22
Year Ago EPS-0.68-0.45-2.69-0.85
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5356
Avg. Estimate2.36M80k2.58M3.85M
Low EstimateN/AN/A200kN/A
High Estimate6.74M150k6.97M15M
Year Ago Sales30kN/A30k2.58M
Sales Growth (year/est)7,766.70%N/A8,500.00%49.20%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.57-0.4-0.39-0.16
EPS Actual-0.68-0.45-0.15-0.17
Difference-0.11-0.050.24-0.01
Surprise %-19.30%-12.50%61.50%-6.30%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.1-0.14-0.85-0.48
7 Days Ago-0.1-0.14-0.85-0.48
30 Days Ago-0.1-0.14-0.85-0.48
60 Days Ago-0.09-0.16-0.85-0.51
90 Days Ago-0.15-0.14-0.91-0.48
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLSDIndustrySectorS&P 500
Current Qtr.85.30%N/AN/A0.01
Next Qtr.68.90%N/AN/A0.06
Current Year68.40%N/AN/A-0.02
Next Year43.50%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A